| 产品详情 |
| Edit |   |
|---|
| Product Name | NKP-1339 |
|---|
| Description | NKP-1339 is the first-in-class ruthenium-based anticancer drug in clinical development against solid cancer and has recently been studied successfully in a phase I clinical trial. |
|---|
| Size | 100 mg, 250 mg, 1 g |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | KP1339,KP 1339,NKP1339,NKP 1339,KP-1339 |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | orb525563 |
|---|
| Price | |
|---|
| Order / More Info | NKP-1339 from BIORBYT LTD. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|